Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,050
Closed -$244K 84
2019
Q3
$244K Hold
1,050
0.14% 70
2019
Q2
$246K Hold
1,050
0.15% 70
2019
Q1
$248K Hold
1,050
0.15% 66
2018
Q4
$316K Sell
1,050
-455
-30% -$145K 0.22% 49
2018
Q3
$532K Hold
1,505
0.35% 31
2018
Q2
$437K Hold
1,505
0.31% 39
2018
Q1
$412K Hold
1,505
0.31% 42
2017
Q4
$479K Hold
1,505
0.37% 34
2017
Q3
$471K Sell
1,505
-40
-3% -$11.8K 0.39% 30
2017
Q2
$419K Buy
1,545
+190
+14% +$50.2K 0.41% 33
2017
Q1
$370K Sell
1,355
-73
-5% -$20.6K 0.38% 40
2016
Q4
$405K Buy
+1,428
New +$423K 0.46% 37

Other funds holding BIIB

REDW Wealth's BIIB Position: Q4 2019 in Review

REDW Wealth sold out of Biogen (BIIB) in Q4 2019, closing a stake of 1,050 shares — an estimated $244K sold.

REDW Wealth first reported a position in BIIB in Q4 2016 and held it in 12 quarters. The position peaked at $532K in Q3 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • REDW Wealth reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • REDW Wealth sold 1,050 Biogen shares in Q4 2019, an estimated $244K.
  • REDW Wealth first reported a position in Biogen in Q4 2016 and held it in 12 quarters.
  • REDW Wealth's Biogen position peaked at $532K in Q3 2018.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on REDW Wealth's 13F filing for Q4 2019, filed 5 Feb 2020.